Categories
Jump to navigation
Jump to search
The following categories exist on the wiki, and may or may not be unused. Also see wanted categories.
(first | last) View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- 5 alpha-reductase inhibitors (2 members)
- ACVR1 inhibitors (1 member)
- AKT1 inhibitors (4 members)
- ALK inhibitors (9 members)
- AXL inhibitors (2 members)
- AbbVie product (1 member)
- Acid pump antagonists (1 member)
- Acquired coagulopathy medications (2 members)
- Acquired coagulopathy regimens (1 member)
- Acquired hemophilia A medications (7 members)
- Acquired hemophilia A regimens (1 member)
- Acquired thrombotic thrombocytopenic purpura medications (7 members)
- Acquired thrombotic thrombocytopenic purpura regimens (1 member)
- Acute leukemias (16 members)
- Acute lymphoblastic leukemia, infant medications (4 members)
- Acute lymphoblastic leukemia, infant regimens (2 members)
- Acute lymphoblastic leukemia medications (1 member)
- Acute lymphoblastic leukemia regimens (3 members)
- Acute lymphoblastic leukemias (10 members)
- Acute myeloid leukemia medications (40 members)
- Acute myeloid leukemia medications (historic) (11 members)
- Acute myeloid leukemia medications (investigational) (10 members)
- Acute myeloid leukemia regimens (9 members)
- Acute promyelocytic leukemia medications (16 members)
- Acute promyelocytic leukemia regimens (2 members)
- Adrenal suppressant (1 member)
- Adrenergic receptor agonists (1 member)
- Adrenocortical carcinoma medications (6 members)
- Adrenocortical carcinoma medications (investigational) (1 member)
- Adrenocortical carcinoma regimens (2 members)
- Adult T-cell leukemia-lymphoma medications (17 members)
- Adult T-cell leukemia-lymphoma regimens (2 members)
- Adult T-cell leukemia/lymphoma medications (0 members)
- Adult T-cell leukemia/lymphoma regimens (0 members)
- Aggressive lymphomas (7 members)
- Aggressive non-Hodgkin lymphomas (11 members)
- Alkalinization (1 member)
- Alkyl sulfonates (1 member)
- Alkylating agents (34 members)
- Allogeneic HSCT regimens (1 member)
- Alloimmune hematologic conditions (1 member)
- Alpha emitters (1 member)
- Alveolar soft part sarcoma medications (1 member)
- Alveolar soft part sarcoma regimens (1 member)
- Aminopeptidase inhibitor (1 member)
- Anabolic steroids (2 members)
- Anal cancer medications (11 members)
- Anal cancer regimens (1 member)
- Anaplastic glioma medications (16 members)
- Anaplastic glioma regimens (2 members)